SOURCE: GeneThera, Inc.

April 11, 2007 09:00 ET

GeneThera Developing Marketing Plan for Mad Cow Testing

WHEAT RIDGE, CO -- (MARKET WIRE) -- April 11, 2007 -- GeneThera, Inc. (OTCBB: GTHA) announced today it is developing a comprehensive marketing program for its Mad Cow testing kit for use within the United States. The marketing campaign will be designed to build brand awareness with the ranchers and slaughterhouses as well as reinforce the need for to test all cattle for Mad Cow. The United States slaughters approximately 35 million cattle per year.

Dr Tony Milici, CEO of GeneThera, stated, "GeneThera intends to start Mad Cow Disease testing as soon as private companies will be allowed to do so. We believe that there will be a great demand by meatpackers for this kind of testing once any government restraints are removed. If meatpackers advertise their product as Mad Cow free, it should also be possible for the US beef industry to fully regain access to international markets such as Japan and Korea."

On March 29, 2007, a federal judge ruled that the federal government must allow meatpackers to test their animals for Mad Cow Disease. If a slaughterhouse or rancher is able to advertise its meat as tested and safe from Mad Cow it could essentially force the larger companies to test also.

ABOUT GENETHERA, INC.:

GeneThera, Inc. is a molecular biotechnology company located in Wheat Ridge, CO. The Company provides genetic diagnostic solutions for the veterinary and agricultural industries with future plans to include the health-care industry. The Company's proprietary diagnostic solution is based on a genetic expression assay, GEA™, a protocol designed to function on a highly automated Fluorogenic PCR platform. This platform enables GeneThera to offer tests that are presently not available from other technologies. The GEA is designed for a host of individual diseases, the current priority being Mad Cow Disease, Chronic Wasting Disease, a disease affecting elk and deer in North America; E.Coli 0157:H7 and Johnne's Disease, diseases affecting cattle worldwide.

"Safe Harbor" Statement: Certain statements in this release are "forward-looking" statements as defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to numerous risks and uncertainties. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause actual results to materially differ from forward-looking statements include, but are not limited to, the Company's ability to meet the terms and conditions required to obtain its project financing, risks and delays associated with product development, risk of market acceptance of new products, risk of technology or product obsolescence, competitive risks, reliance on development partners and the need for additional capital.